Source: Breathe 2005; 2: 123-124



Rating:

Share or cite this content

Citations should be made in the following way:
P. Diot, W. MacNee, W. Kreyling, R. Dahl, B. Laube, G. V. ERS and ISAM: a significant progression. Breathe 2005; 2: 123-124

Member's Comments

No comment yet.

Related content which might interest you: Late-breaking abstract: Lung regional differences in tissue adaptation to chronic hypoxia (CH) Source: Annual Congress 2011 - Lung cell biology Year: 2011 Umeclidinium/vilanterol in preventing clinically important deterioration (CID) in COPD and impact of baseline disease severity: the EMAX trial Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 ERS / ATS workshop on longitudinal analysis of pulmonary function data Source: Guideline 1997 Year: 1997 Early Career Members at the ERS LSC 2017: mechanistic overlap between chronic lung injury and cancer Source: Breathe, 13 (4) 323; 10.1183/20734735.010217 Year: 2017 The ERS Guideline development process Source: International Congress 2017 – Making ERS guidelines usable and relatable Year: 2017 An official ERS technical standard: exhaled biomarkers in lung disease Source: International Congress 2016 – ERS statements and technical standards Year: 2016 ERS activities: how to get involved Source: Virtual Congress 2021 – Keys to success in science Year: 2021 Smokehaz: a new ERS resource for controlling smoking Source: International Congress 2014 – Pulmonary disorders associated with passive smoking: new online ERS resources Year: 2014 Sex-related differences in emphysema progression Source: International Congress 2014 – From lung imaging research to clinical use Year: 2014 ERJ November Podcast: ERS statement on the diagnosis and treatment of pulmonary disease caused by a1-antitrypsin deficiency Source: Eur Respir J, 50 (5) 17E5005; 10.1183/13993003.E5005-2017 Year: 2017 ERS guidelines: the employed methodology Source: International Congress 2019 – Guidelines for long-term non-invasive ventilation in chronic obstructive pulmonary disease Year: 2019 ERS PCD task force recommendations for diagnostic testing Source: International Congress 2016 – Diagnosing primary ciliary dyskinesia (PCD) in a molecular age Year: 2016 Minimal clinically important difference for asthma endpoints: an expert consensus report Source: Eur Respir Rev, 29 (156) 190137; 10.1183/16000617.0137-2019 Year: 2020 The progressive fibrotic phenotype in ILDs: can it be reliably recognised at baseline evaluation? Source: International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases Year: 2019 ERS technical standard: Exhaled biomarkers in lung disease Source: International Congress 2017 – ERS statements and technical standards on diagnosis and monitoring Year: 2017 Rheumatoid factor as the new predictive marker of reduced lung function: A cross-sectional study Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 CME test: ERS Monograph 64: Cystic fibrosis Source: Year: 2014 How we do it: treating PCD in Europe, the results of the ERS Task Force Source: Annual Congress 2008 - ERS Task Force report: primary ciliary dyskinesia (PCD) in children Year: 2008